Habtewold, A., Amogne, W., Makonnen, E., Yimer, G., Nylén, H., Riedel, K., . . . Aklillu, E. (2013). Pharmacogenetic and pharmacokinetic aspects of CYP3A induction by efavirenz in HIV patients. Pharmacogenomics Journal, 13(6), 484. https://doi.org/10.1038/tpj.2012.46
Chicago Style (17th ed.) CitationHabtewold, A., et al. "Pharmacogenetic and Pharmacokinetic Aspects of CYP3A Induction by Efavirenz in HIV Patients." Pharmacogenomics Journal 13, no. 6 (2013): 484. https://doi.org/10.1038/tpj.2012.46.
MLA (9th ed.) CitationHabtewold, A., et al. "Pharmacogenetic and Pharmacokinetic Aspects of CYP3A Induction by Efavirenz in HIV Patients." Pharmacogenomics Journal, vol. 13, no. 6, 2013, p. 484, https://doi.org/10.1038/tpj.2012.46.
Warning: These citations may not always be 100% accurate.